Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 112   

Articles published

SHP 5,181.10 +21.10 (0.41%)
price chart
Exclusive: Shire Plc moves to prepare Salix bid - sources
(Reuters) - British pharmaceutical company Shire Plc (SHP.L) has taken initial steps towards a bid for U.S. bowel drugmaker Salix Pharmaceuticals Inc (SLXP.
Valeant Said to Secure Salix Financing, Closing In on Offer  Bloomberg
Why GlaxoSmithKline plc And Shire plc Are Dividend And Growth Buys
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) would be my pick of the pharmaceutical companies to invest in at the moment.
Are These The FTSE's Strongest Dividends? ARM Holdings plc, Shire PLC ...
Which firms pay really safe dividends? Two years ago, you might have said Tesco - the UK's largest supermarket had increased its payout for 18 consecutive years.
Here's Why The Market Hates GlaxoSmithKline plc, But Loves Shire plc
I am attracted to Shire because it has been much more aggressive than its rivals in its corporate strategy, as its latest purchase of NPS Pharmaceuticals signals. Shire is exploiting its balance sheet at a time other pharma players have been more ...
Shire plc (SHPG) to Acquire Meritage Pharma in $70M + Milestones Deal
Shire plc (Nasdaq: SHPG) and Meritage Pharma, Inc. announced today that Shire has acquired Meritage, a privately-held company, for an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory ...
Shire PLC (ADR) (NASDAQ:SHPG) Buys Meritage Pharma In $70M+ Deal  InvestCorrectly
Shire gobbles up privately-held pharma firm (SHPG)  Seeking Alpha (registration)
Shire PLC Price Target Raised to GBX 6400 at Goldman Sachs (SHP)
Shire PLC logo Equities researchers at Goldman Sachs raised their target price on shares of Shire PLC (LON:SHP) from GBX 5,600 ($86.30) to GBX 6,400 ($98.63) in a research report issued on Tuesday.
Shire PLC Upgraded by AlphaValue to "Buy" (SHP)  Mideast Time
Whitbread plc Earns "Outperform" Rating from Credit Suisse (WTB)  Dakota Financial News
Short Interest in Shire PLC Increases By 48.4% (SHPG)
Shire PLC logo Shares of Shire PLC (NASDAQ:SHPG) saw a significant growth in short interest in the month of February.
Shire plc (NASDAQ:SHPG) Update: Shire submits application to FDA for ...  Wall Street Pulse
Shire plc (SHPG) Completes NPS Pharma (NPSP) Purchase
Shire plc (NASDAQ: SHPG) the successful completion of the tender offer for all of the outstanding shares of NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) and the subsequent acquisition of NPS Pharma.
Shire Plc Announces Successful Completion NPS Pharma Acquisition - Quick ...
NPS Pharma became a wholly owned subsidiary of Shire and NPS Pharma's shares ceased to be traded on NASDAQ. For comments and feedback: contact editorial@rttnews.
Shire announces completion of NPS Pharma acquisition  News-Medical.net
Shire Profit Surges Thanks to AbbVie Breakup Fee
Fourth-quarter profit at Shire PLC surged to $2.17 billion thanks to the breakup fee received from AbbVie Inc., as the drug maker said it is looking forward to new-product launches this year to help offset a key patent loss and the stronger dollar ...
Shire plc (SHPG) Misses Q4 EPS by 10c, Offers Outlook  StreetInsider.com
Shire Forecasts Higher Earnings in 2015 After NPS Acquisi  Bloomberg